Literature DB >> 30625358

Post-translational modifications on glycated plasma fibrinogen: A physicochemical insight.

Shahida Perween1, Minhal Abidi1, Abul Faiz Faizy1.   

Abstract

Methylglyoxal (MGO) is a highly reactive α-oxoaldehyde. It reacts with basic amino acids of the proteins to form advanced glycation end products (AGEs). Fibrinogen is a soluble multi-domain glycoprotein whose major function is to form fibrin clots that prevent blood loss upon vascular injury. In the present study, fibrinogen was incubated with varying concentration of MGO for 7 days followed by its biochemical and biophysical analysis. Glycated plasma fibrinogen (MGO-fibrinogen); exhibited hyperchromicity, a drop in tryptophan and intrinsic fluorescence, augmented AGE-specific fluorescence and melting temperature. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) results showed decrease in mobility of MGO-fibrinogen. Structural perturbations in secondary and tertiary structure were identified by fourier transform-infrared spectroscopy (FT-IR), followed by far and near-UV circular dichroism (CD). Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF-TOF) mass spectrometry studies suggested increase in molecular mass of MGO-fibrinogen. Amyloid like aggregates were confirmed by Thioflavin T (ThT), Congo red assay (CR), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The ketoamine moieties, carbonyl content (CO), hydroxymethylfurfural (HMF), superoxide and hydroxyl content were markedly elevated, whereas, total antioxidant capacity (TAC) and free thiol content decreased in MGO-fibrinogen as compared to the native protein. These investigations confirmed the structural and functional alterations in MGO-fibrinogen which leads to different physiological conditions like diabetes mellitus, cardiovascular disease etc.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Advanced glycation end products; Atherosclerosis; Diabetes; Fibrinogen; Methylglyoxal; Reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 30625358     DOI: 10.1016/j.ijbiomac.2019.01.018

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

1.  Multimodal imaging of hemorrhagic transformation biomarkers in an ischemic stroke model.

Authors:  M J Pushie; M Messmer; N J Sylvain; J Heppner; J M Newton; H Hou; M J Hackett; M E Kelly; L Peeling
Journal:  Metallomics       Date:  2022-04-30       Impact factor: 4.636

2.  Anthropometric Measurements, Metabolic Profile and Physical Fitness in a Sample of Spanish Women with Type 2 Diabetes.

Authors:  María Orosia Lucha-López; Concepción Vidal-Peracho; César Hidalgo-García; Jacobo Rodríguez-Sanz; Héctor Tricás-Vidal; Mar Hernández-Secorún; Sofía Monti-Ballano; José Miguel Tricás-Moreno; Ana Carmen Lucha-López
Journal:  Int J Environ Res Public Health       Date:  2021-11-14       Impact factor: 3.390

3.  Proteins in human body fluids contain in vivo antigen analog of the melibiose-derived glycation product: MAGE.

Authors:  Kinga Gostomska-Pampuch; Andrzej Gamian; Karol Rawicz-Pruszyński; Katarzyna Gęca; Joanna Tkaczuk-Włach; Ilona Jonik; Kinga Ożga; Magdalena Staniszewska
Journal:  Sci Rep       Date:  2022-05-07       Impact factor: 4.996

4.  Fibrinogen Glycation and Presence of Glucose Impair Fibrin Polymerization-An In Vitro Study of Isolated Fibrinogen and Plasma from Patients with Diabetes Mellitus.

Authors:  Boguslawa Luzak; Magdalena Boncler; Marcin Kosmalski; Ewelina Mnich; Lidia Stanczyk; Tomasz Przygodzki; Cezary Watala
Journal:  Biomolecules       Date:  2020-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.